BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6210826)

  • 1. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates.
    Lottenberg R; Christensen U; Jackson CM; Coleman PL
    Methods Enzymol; 1981; 80 Pt C():341-61. PubMed ID: 6210826
    [No Abstract]   [Full Text] [Related]  

  • 2. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small synthetic peptides with affinity for proteases in coagulation and fibrinolysis: an overview.
    Claeson G; Aurell L
    Ann N Y Acad Sci; 1981; 370():798-811. PubMed ID: 6455958
    [No Abstract]   [Full Text] [Related]  

  • 4. New chromogenic substrates for thrombin with increased specificity.
    Kolde HJ; Eberle R; Heber H; Heimburger N
    Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitive colorimetric assay for various proteases using naphthyl ester derivatives as substrates.
    Niinobe M; Hitomi Y; Fujii S
    J Biochem; 1980 Mar; 87(3):779-83. PubMed ID: 6446549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive fluorogenic substrates for serine proteases.
    Butenas S; DiLorenzo ME; Mann KG
    Thromb Haemost; 1997 Oct; 78(4):1193-201. PubMed ID: 9364984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 8. Action of crotalase, an enzyme with thrombin-like and kallikrein-like specificities, on tripeptide nitroanilide derivatives.
    Simmons G; Bundalian M; Theodor I; Martinoli J; Pirkle H
    Thromb Res; 1985 Nov; 40(4):555-61. PubMed ID: 2934864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity and specificity of plasma serine protease chromogenic substrates.
    Bang NU; Mattler LE
    Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 11. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-anthraniloylation converts peptide p-nitroanilides into fluorogenic substrates of proteases without loss of their chromogenic properties.
    Bratovanova EK; Petkov DD
    Anal Biochem; 1987 Apr; 162(1):213-8. PubMed ID: 3300413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorogenic peptide substrates for proteases in blood coagulation, kallikrein-kinin and fibrinolysis systems.
    Iwanaga S; Morita T; Kato H; Harada T; Adachi N; Sugo T; Maruyama I; Takada K; Kimura T; Sakakibara S
    Adv Exp Med Biol; 1979; 120A():147-63. PubMed ID: 158955
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling serine protease substrate specificity with solution phase fluorogenic peptide microarrays.
    Gosalia DN; Salisbury CM; Maly DJ; Ellman JA; Diamond SL
    Proteomics; 2005 Apr; 5(5):1292-8. PubMed ID: 15742319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coagulation of blood: preliminary survey of thrombin and autoprothrombin zymogen structure.
    Seegers WH; Murano G; McCoy L; Marciniak E
    Life Sci; 1969 Sep; 8(18):925-32. PubMed ID: 5346943
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic peptide substrates in hemostatic testing.
    Fareed J; Messmore HL; Walenga JM; Bermes EW
    Crit Rev Clin Lab Sci; 1983; 19(2):71-134. PubMed ID: 6373139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monitoring anticoagulant treatment with the KEM-O-MAT 2HP autoanalyzer].
    Laharrague P; Leleu T; Poignot JL; Cambus JP; Biermé R
    Nouv Rev Fr Hematol (1978); 1983; 25(2):107-12. PubMed ID: 6866753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay with chromogenic substrates of in vivo activated proteases.
    Fässler H; Duckert F; Marbet GA
    Haemostasis; 1978; 7(2-3):158-63. PubMed ID: 149048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are synthetic inhibitors able to improve factor Xa assays using peptide substrates?
    Stürzebecher J; Markwardt F; Wagner G; Voigt B
    Thromb Res; 1982 May; 26(3):221-6. PubMed ID: 7112515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.